Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 178,023 | 167,117 | 181,244 | 163,926 | 169,467 |
| Cost of Goods | 44,262 | 47,416 | 47,692 | 39,750 | 48,207 |
| Gross Profit | 133,761 | 119,701 | 133,552 | 124,176 | 121,260 |
| Operating Expenses | 105,783 | 106,905 | 101,076 | 107,205 | 81,590 |
| Operating Income | 28,240 | 13,212 | 33,168 | 17,721 | 39,877 |
| Interest Expense | 3,884 | 3,316 | 3,388 | 3,464 | 3,865 |
| Other Income | 12,228 | 3,744 | 3,940 | 2,344 | 1,842 |
| Pre-tax Income | 36,584 | 13,640 | 33,720 | 16,601 | 37,854 |
| Income Tax | 17,698 | 4,661 | 8,850 | 5,743 | 12,091 |
| Net Income Continuous | 18,886 | 8,979 | 24,870 | 10,858 | 25,763 |
| Net Income | $18,886 | $8,979 | $24,870 | $10,858 | $25,763 |
| EPS Basic Total Ops | 0.41 | 0.19 | 0.55 | 0.23 | 0.56 |
| EPS Basic Continuous Ops | 0.41 | 0.19 | 0.54 | 0.23 | 0.56 |
| EPS Diluted Total Ops | 0.39 | 0.19 | 0.58 | 0.23 | 0.51 |
| EPS Diluted Continuous Ops | 0.37 | 0.17 | 0.53 | 0.21 | 0.49 |
| EPS Diluted Before Non-Recurring Items | 0.64 | 0.42 | 0.71 | N/A | N/A |
| EBITDA(a) | $47,889 | $32,343 | $52,362 | $36,862 | $59,650 |